(R)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHAN-1-AMINE HCL, 95.0%, 250mg

(2E)-2-[(4-methylbenzoyl)amino]-3-phenylacrylic acid, 95.0%, 500mg

(S)-1-(2-Chlorophenyl)-N-methylethan-1-amine, 95%, 250mg

8-Bromoquinoline-4-ol, 95.0%, 25g

Bis(1,5-cyclooctadiene)diiridium(I) dichloride, 98.0%, 500mg

((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate, 98.0%, 25g

1,2-Dimethoxyethane, min. 99%, for synthesis, 100 ml, glass packaging

2,2-Bis[4-(4-maleimidophenoxy)phenyl]propane>98.0%(HPLC)(N)25g

tert-Butyl 4-(4-bromo-3-(trifluoromethyl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, 95.0%, 250mg

Reaction vial stands ROTILABO® 2-in-1, blue, 5 Piece(s)

DL-Arabinose>98.0%(HPLC)5g

1-Phenylimidazole>98.0%(GC)1g

7H-Pyrrolo[2,3-d]pyrimidine-5-carbaldehyde, 95.0%, 50g